Hemostatic abnormalities in adult patients with Marfan syndrome

Katharina T I Kornhuber1, Heide Seidel1,2, Claudia Pujol1

  • 1Department of Congenital Heart Disease and Pediatric Cardiology, German Heart Center Munich, Technical University Munich, Munich, Germany.

Abstract

Insights

Patients with Marfan syndrome (MFS) exhibit significant hemostatic deviations, including altered platelet function and increased D-dimers, linked to aortic root ectasia. These findings highlight potential bleeding risks in MFS patients.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Genetics

Background:

  • Marfan syndrome (MFS) is associated with aortic root ectasia, potentially impacting hemostasis due to altered blood flow.
  • Understanding hemostatic changes in MFS is crucial for managing associated cardiovascular risks.

Purpose of the Study:

  • To investigate and compare hemostasis in patients with Marfan syndrome (MFS) against healthy controls.
  • To explore the relationship between aortic root dimensions and coagulation status in MFS.

Main Methods:

  • A cross-sectional case-control study included 51 MFS patients and 50 healthy controls.
  • Aortic root dimensions were assessed using echocardiography and cardiac MRI.
  • Coagulation status was evaluated using Multiplate®, PFA-100®, PTT, D-dimers, von Willebrand factor (VWF) activity/antigen, and factor VIII activity.

Main Results:

  • MFS patients displayed significantly larger aortic root diameters and Z-scores compared to controls.
  • Elevated Multiplate® (MP-ADP) and PFA-100® (PFA Col/ADP) test values, along with increased D-dimers, were observed in MFS patients.
  • Reduced VWF activity/antigen and factor VIII activity were noted in MFS patients, with significant correlations between aortic diameter and D-dimers/PFA Col/ADP, and an inverse correlation with factor VIII activity.

Conclusions:

  • The study confirms significant hemostatic deviations in patients with Marfan syndrome.
  • Aortic root ectasia in MFS is associated with distinct alterations in platelet function, coagulation, and fibrinolysis.
  • Further research is warranted to elucidate the precise pathomechanisms and causal relationships involved.

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.9K
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
240
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
310
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
163
Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
773